Koers Aurora Cannabis Inc Toronto S.E.
Aandelen
CA7561027037
Farmaceutische producten
Omzet 2024 * | 272 mln. 199 mln. 184 mln. | Omzet 2025 * | 320 mln. 234 mln. 216 mln. | Marktkapitalisatie | 496 mln. 364 mln. 336 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -61 mln. -44,69 mln. -41,3 mln. | Nettowinst (verlies) 2025 * | -7 mln. -5,13 mln. -4,74 mln. | EV/omzet 2024 * | 1,82 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,55 x |
K/w-verhouding 2024 * |
-5,81
x | K/w-verhouding 2025 * |
-56
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 100% |
Recentste transcriptie over Aurora Cannabis Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Miguel Martin
CEO | Chief Executive Officer | 52 | 06-07-20 |
Simona King
DFI | Director of Finance/CFO | 52 | 21/02 |
Dave Aird
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Funk
CHM | Chairman | 67 | 25-07-18 |
Michael Singer
BRD | Director/Board Member | 60 | 20-05-16 |
Adam Szweras
BRD | Director/Board Member | 52 | 10-08-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+44,36% | 6,29 mld. | |
-13,52% | 4,55 mld. | |
+10,85% | 3,27 mld. | |
-6,52% | 3,23 mld. | |
-0,71% | 2,56 mld. | |
+51,14% | 2 mld. | |
-5,22% | 1,68 mld. | |
+1,29% | 1,64 mld. | |
+57,69% | 1,6 mld. |